Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Company Announcements
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
2d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Clarifies Member Register Closure Procedures
9d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech’s New Drug Application for HLX04-O Accepted by NMPA
11d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Announces Extraordinary General Meeting for Key Resolutions
12d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Announces New Board Appointments
16d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
17d ago
2696
Premium
Company Announcements
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
18d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Schedules Board Meeting to Discuss Interim Results and Dividend
23d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech’s HLX14 Receives Positive EMA Opinion
27d ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Approves Key Resolutions at 2025 EGM
1M ago
2696
Premium
Company Announcements
Shanghai Henlius Initiates Phase 3 Trial of HLX22 in the US
1M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Announces EGM to Approve Share Schemes
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Secures EU GMP Certification for Key Biosimilars
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Secures Exclusive Rights for HCB101 Development
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Proposes New Share Option and RSU Schemes
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Proposes Governance Amendments and Committee Appointments
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Updates Nomination Committee Terms
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Announces Board Composition and Roles
2M ago
2696
Premium
Ratings
Shanghai Henlius Biotech: Promising Drug Pipeline and Strategic Partnerships Drive Buy Rating
2M ago
Premium
Company Announcements
Shanghai Henlius Initiates Japanese Study for Cancer Treatment
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
2M ago
2696
Premium
Company Announcements
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
3M ago
2696
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.